Fortnightly review: modern drug treatment of chronic asthma.
作者信息
Lipworth B J
机构信息
Department of Clinical Pharmacology and Therapeutics, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY.
出版信息
BMJ. 1999 Feb 6;318(7180):380-4. doi: 10.1136/bmj.318.7180.380.
Abstract
摘要
相似文献
1
Fortnightly review: modern drug treatment of chronic asthma.双周综述：慢性哮喘的现代药物治疗
BMJ. 1999 Feb 6;318(7180):380-4. doi: 10.1136/bmj.318.7180.380.
2
Asthma.哮喘
N Engl J Med. 2009 Mar 5;360(10):1002-14. doi: 10.1056/NEJMra0804579.
3
[Current recommendation for asthma treatment].[哮喘治疗的当前推荐]
Pol Merkur Lekarski. 2004 May;16 Suppl 1:24-9.
4
Asthma.哮喘
Clin Evid. 2005 Dec(14):1847-77.
5
Adenosine monophosphate bronchial provocation and the actions of asthma therapy.单磷酸腺苷支气管激发试验与哮喘治疗的作用
Clin Exp Allergy. 2003 Mar;33(3):287-94. doi: 10.1046/j.1365-2745.2003.01620.x.
6
[Diagnostics and therapy of asthma].[哮喘的诊断与治疗]
Duodecim. 2000;116(22):2568-84.
7
Combination therapy: addition of other long-term-control medications to inhaled corticosteroids.联合治疗：在吸入性糖皮质激素基础上加用其他长期控制药物。
J Allergy Clin Immunol. 2002 Nov;110(5 Suppl):S169-80. doi: 10.1016/s0091-6749(02)80007-0.
8
Advances in pharmacotherapy of asthma.哮喘药物治疗的进展
Curr Probl Dermatol. 1999;28:135-52. doi: 10.1159/000060588.
9
Asthma and other wheezing disorders in children.儿童哮喘及其他喘息性疾病
Clin Evid. 2005 Dec(14):238-62.
10
New combination therapies for asthma.哮喘的新型联合疗法。
Curr Opin Pulm Med. 2001 Mar;7(2):62-8. doi: 10.1097/00063198-200103000-00002.
引用本文的文献
1
Maternal asthma medication use and the risk of selected birth defects.母亲哮喘药物使用与某些出生缺陷风险。
Pediatrics. 2012 Feb;129(2):e317-24. doi: 10.1542/peds.2010-2660. Epub 2012 Jan 16.
2
Maternal asthma medication use and the risk of gastroschisis.孕期哮喘药物使用与腹裂的风险
Am J Epidemiol. 2008 Jul 1;168(1):73-9. doi: 10.1093/aje/kwn098. Epub 2008 Apr 23.
3
Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma.低剂量和高剂量吸入性糖皮质激素对轻度哮喘吸烟者与非吸烟者的疗效比较
Thorax. 2005 Apr;60(4):282-7. doi: 10.1136/thx.2004.033688.
4
Differential regulation of the release of tumor necrosis factor-alpha and of eicosanoids by mast cells in rat airways after antigen challenge.抗原激发后大鼠气道中肥大细胞对肿瘤坏死因子-α和类花生酸释放的差异调节。
Mediators Inflamm. 2003 Aug;12(4):237-46. doi: 10.1080/09629350310001599684.
5
Antagonism of long-acting beta2-adrenoceptor agonism.长效β2肾上腺素能激动剂的拮抗作用。
Br J Clin Pharmacol. 2002 Sep;54(3):231-45. doi: 10.1046/j.1365-2125.2002.01651.x.
6
Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma.吸入用糠酸莫米松：用于成人和青少年持续性哮喘的应用综述
Drugs. 2001;61(9):1325-50. doi: 10.2165/00003495-200161090-00011.
7
Safety of inhaled and intranasal corticosteroids: lessons for the new millennium.吸入和鼻内用皮质类固醇的安全性：新千年的经验教训。
Drug Saf. 2000 Jul;23(1):11-33. doi: 10.2165/00002018-200023010-00002.
8
Montelukast: a review of its therapeutic potential in persistent asthma.孟鲁司特：对其在持续性哮喘中治疗潜力的综述
Drugs. 2000 Apr;59(4):891-928. doi: 10.2165/00003495-200059040-00015.
本文引用的文献
1
Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.孟鲁司特与氯雷他定联合治疗季节性变应性鼻炎：一项随机、安慰剂对照临床试验
J Allergy Clin Immunol. 2000 May;105(5):917-22. doi: 10.1067/mai.2000.106040.
2
Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma.白三烯受体拮抗剂普仑司特对哮喘患者支气管黏膜细胞浸润的影响。
Thorax. 1998 Oct;53(10):835-41. doi: 10.1136/thx.53.10.835.
3
Potential masking effects of salmeterol on airway inflammation in asthma.沙美特罗对哮喘气道炎症的潜在掩盖作用。
Am J Respir Crit Care Med. 1998 Sep;158(3):924-30. doi: 10.1164/ajrccm.158.3.9802069.
4
Effects of treatment with formoterol on bronchoprotection against methacholine.福莫特罗治疗对乙酰甲胆碱支气管保护作用的影响。
Am J Med. 1998 May;104(5):431-8. doi: 10.1016/s0002-9343(98)00086-2.
5
Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.孟鲁司特，一种每日一次的白三烯受体拮抗剂，用于治疗慢性哮喘：一项多中心、随机、双盲试验。孟鲁司特临床研究组。
Arch Intern Med. 1998 Jun 8;158(11):1213-20. doi: 10.1001/archinte.158.11.1213.
6
Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group.孟鲁司特治疗6至14岁儿童慢性哮喘：一项随机双盲试验。儿科孟鲁司特研究组
JAMA. 1998 Apr 15;279(15):1181-6. doi: 10.1001/jama.279.15.1181.
7
Leukotriene modifiers in the treatment of asthma. Look promising across the board of asthma severity.白三烯调节剂在哮喘治疗中的应用。在各类哮喘严重程度中看起来都很有前景。
BMJ. 1998 Apr 25;316(7140):1257-8. doi: 10.1136/bmj.316.7140.1257.
8
Effect of asthma and its treatment on growth: four year follow up of cohort of children from general practices in Tayside, Scotland.哮喘及其治疗对生长发育的影响：对苏格兰泰赛德地区全科医疗中儿童队列的四年随访
BMJ. 1998 Feb 28;316(7132):668-72. doi: 10.1136/bmj.316.7132.668.
9
Efficacy and safety of inhaled corticosteroids. New developments.吸入性糖皮质激素的疗效与安全性。新进展。
Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 2):S1-53. doi: 10.1164/ajrccm.157.3.157315.
10
Effects of budesonide and fluticasone on 24-hour plasma cortisol. A dose-response study.布地奈德和氟替卡松对24小时血浆皮质醇的影响。一项剂量反应研究。
Am J Respir Crit Care Med. 1997 Dec;156(6):1746-51. doi: 10.1164/ajrccm.156.6.9703003.
Zotero 插件